This study is in progress, not accepting new patients
A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Costa Mesa, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Ipsen
- ID
- NCT04083235
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Last Updated